封面
市场调查报告书
商品编码
1602836

抗菌成分市场:按类型、最终用户划分 - 2025-2030 年全球预测

Antimicrobial Ingredients Market by Type (Inorganic, Organic), End-User (Automotive & Transportation, Building & Construction, Food & Beverage) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗菌成分市值为44.2亿美元,预计2024年将达47亿美元,复合年增长率为6.79%,预计2030年将达70亿美元。

抗菌成分的范围和定义包括抑制细菌、病毒和真菌等微生物生长的化合物。这些成分对于维持製药、食品和饮料、个人护理和医疗领域产品的安全性和有效性至关重要。由于卫生和安全意识的提高、感染疾病的爆发以及产品配方的严格监管标准,这项需求更加突出。这些成分的应用非常广泛,包括医院、食品加工设备和消费品製造等各种最终用途行业中的消毒剂、防腐剂和治疗剂。根据市场洞察,关键的成长要素包括对天然和永续抗菌解决方案的需求激增、成分合成的技术进步以及强劲的研发活动。由于卫生措施的加强和消费者健康意识的提高,COVID-19 大流行也增加了市场需求,为市场参与企业和现有企业创新和扩大产品系列创造了重要机会。然而,挑战包括监管障碍、微生物对传统抗生素具有抗药性的新兴国家的开拓中市场,以及基于化学的选择可能产生的副作用和毒性。特别是在法律规范严格的地区,这可能会阻碍我们产品的核准和商业化。为了利用成长机会,公司需要专注于天然抗菌剂的创新应用,投资于永续且毒性较小的替代品的研究,并建立战略伙伴关係以在全球范围内企业发展。此外,我们可以透过加强技术力来提高功效和开发多功能抗菌剂来增强我们的竞争力。该市场的特点是转向环保和消费者安全的产品,生物分解性和植物来源抗菌药物的创新和研究被证明是一个利润丰厚的领域。

主要市场统计
基准年[2023] 44.2亿美元
预测年份 [2024] 47亿美元
预测年份 [2030] 70亿美元
复合年增长率(%) 6.79%

市场动态:揭示快速发展的抗菌成分市场的关键市场洞察

供需的动态交互作用正在改变抗菌成分市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 提高对健康和卫生问题的认识
    • 对消毒剂和表面消毒剂的需求不断增长
    • 可支配所得增加,抗菌化妆品采用率上升
  • 市场限制因素
    • 与抗菌成分原料和配方相关的成本上升
  • 市场机会
    • 转向植物来源抗菌产品
    • 推出新开发的抗菌成分
  • 市场问题
    • 抗菌成分严格核准流程

波特五力:引领抗菌成分市场的策略工具

波特的五力框架是了解抗菌成分市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点,避免潜在的挑战,确保更强大的市场地位。

PESTLE分析:了解抗菌成分市场的外部影响

外部宏观环境因素对抗菌成分市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析:了解抗菌成分市场竞争状况

抗菌成分市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵:抗菌成分市场供应商绩效评估

FPNV定位矩阵是评估抗菌成分市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议:绘製抗菌成分市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,抗菌成分市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率:详细检视当前市场环境,主要企业的广泛资料,评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有细分市场的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品和地区提供最佳投资机会?

3.塑造市场的关键技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高对健康和卫生问题的认识
      • 消毒剂和表面消毒剂的需求增加
      • 可支配收入的增加和抗菌化妆品的使用增加
    • 抑制因素
      • 与原料和抗菌配方相关的成本增加
    • 机会
      • 植物来源抗菌产品的趋势
      • 推出新开发的抗菌成分
    • 任务
      • 抗菌成分严格的核准流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章抗菌成分市场:依类型

  • 介绍
  • 无机的
  • 有机的

第七章抗菌成分市场:依最终用户分类

  • 介绍
  • 汽车/交通
  • 建筑/施工
  • 饮食
  • 医疗保健
  • 纤维

第八章 南北美洲抗菌成分市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太抗菌成分市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东及非洲抗菌成分市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Ashland Global Holdings Inc
  • Avient Corporation
  • BASF SE
  • BioCote Limited
  • Clariant AG
  • Croda International PLC
  • Destiny Pharma PLC
  • DuPont de Nemours, Inc.
  • HeiQ PLC
  • Kemin Industries, Inc.
  • Lonza Group AG
  • LyondellBasell Industries Holdings BV
  • Merck KGaA
  • Microban International, Ltd.
  • Milliken & Company
  • Momentive Performance Materials Inc
  • NATUREX SA
  • Nouryon Chemicals Holding BV
  • Pfizer Inc.
  • RTP Company
  • Sanitized AG
  • Solvay SA
  • Stepan Company
  • Symrise AG
  • Wacker Chemie AG
Product Code: MRR-69324464D0CE

The Antimicrobial Ingredients Market was valued at USD 4.42 billion in 2023, expected to reach USD 4.70 billion in 2024, and is projected to grow at a CAGR of 6.79%, to USD 7.00 billion by 2030.

The scope and definition of antimicrobial ingredients encompass compounds that inhibit the growth of microorganisms such as bacteria, viruses, and fungi. These ingredients are crucial in preserving the safety and efficacy of products in pharmaceuticals, food and beverages, personal care, and healthcare sectors. Their necessity is underscored by rising awareness of hygiene and safety, the increasing prevalence of infectious diseases, and stringent regulatory standards governing product formulations. Applications of these ingredients are broad, spanning disinfectants, preservatives, and therapeutic agents in diverse end-use industries like hospitals, food processing units, and consumer goods manufacturing. Market insights reveal that key growth influencers include the surging demand for natural and sustainable antimicrobial solutions, technological advancements in ingredient synthesis, and robust research and development activities. The COVID-19 pandemic has also augmented market demand due to heightened sanitation measures and a rise in consumer health consciousness, presenting significant opportunities for market entrants and established players to innovate and expand their product portfolios. However, the market is challenged by factors such as regulatory hurdles, the development of resistance by microorganisms against conventional antimicrobials, and the potential side effects or toxicity of some chemical-based options. Limitations are particularly pertinent in regions with stringent regulatory frameworks, which can impede product approvals and commercialization. To capitalize on growth opportunities, businesses should focus on innovative applications of natural antimicrobials, invest in research for sustainable and less toxic alternatives, and engage in strategic partnerships to expand their global reach. Furthermore, enhancing technological capabilities for improved efficacy and developing multi-functional antimicrobials can provide a competitive edge. The market is characterized by a shift towards environmentally friendly and consumer-safe products, indicating a lucrative frontier for innovation and research in biodegradable and plant-based antimicrobials.

KEY MARKET STATISTICS
Base Year [2023] USD 4.42 billion
Estimated Year [2024] USD 4.70 billion
Forecast Year [2030] USD 7.00 billion
CAGR (%) 6.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Ingredients Market

The Antimicrobial Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness regarding health and hygiene issues
    • Growing demand for sanitizers and surface disinfectants
    • Rise in disposable income and higher adoption of antimicrobial cosmetic products
  • Market Restraints
    • Rising costs associated with raw materials and formulation of antimicrobial ingredients
  • Market Opportunities
    • Inclination toward plant-based antimicrobial products
    • Launch of newly developed antimicrobial ingredients
  • Market Challenges
    • Stringent approval processes of antimicrobial ingredients

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Ingredients Market

A detailed market share analysis in the Antimicrobial Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antimicrobial Ingredients Market

A strategic analysis of the Antimicrobial Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ashland Global Holdings Inc, Avient Corporation, BASF SE, BioCote Limited, Clariant AG, Croda International PLC, Destiny Pharma PLC, DuPont de Nemours, Inc., HeiQ PLC, Kemin Industries, Inc., Lonza Group AG, LyondellBasell Industries Holdings B.V., Merck KGaA, Microban International, Ltd., Milliken & Company, Momentive Performance Materials Inc, NATUREX SA, Nouryon Chemicals Holding B.V., Pfizer Inc., RTP Company, Sanitized AG, Solvay SA, Stepan Company, Symrise AG, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inorganic and Organic.
  • Based on End-User, market is studied across Automotive & Transportation, Building & Construction, Food & Beverage, Healthcare, and Textile.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness regarding health and hygiene issues
      • 5.1.1.2. Growing demand for sanitizers and surface disinfectants
      • 5.1.1.3. Rise in disposable income and higher adoption of antimicrobial cosmetic products
    • 5.1.2. Restraints
      • 5.1.2.1. Rising costs associated with raw materials and formulation of antimicrobial ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination toward plant-based antimicrobial products
      • 5.1.3.2. Launch of newly developed antimicrobial ingredients
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes of antimicrobial ingredients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antimicrobial Ingredients Market, by Type

  • 6.1. Introduction
  • 6.2. Inorganic
  • 6.3. Organic

7. Antimicrobial Ingredients Market, by End-User

  • 7.1. Introduction
  • 7.2. Automotive & Transportation
  • 7.3. Building & Construction
  • 7.4. Food & Beverage
  • 7.5. Healthcare
  • 7.6. Textile

8. Americas Antimicrobial Ingredients Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antimicrobial Ingredients Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Ingredients Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ashland Global Holdings Inc
  • 2. Avient Corporation
  • 3. BASF SE
  • 4. BioCote Limited
  • 5. Clariant AG
  • 6. Croda International PLC
  • 7. Destiny Pharma PLC
  • 8. DuPont de Nemours, Inc.
  • 9. HeiQ PLC
  • 10. Kemin Industries, Inc.
  • 11. Lonza Group AG
  • 12. LyondellBasell Industries Holdings B.V.
  • 13. Merck KGaA
  • 14. Microban International, Ltd.
  • 15. Milliken & Company
  • 16. Momentive Performance Materials Inc
  • 17. NATUREX SA
  • 18. Nouryon Chemicals Holding B.V.
  • 19. Pfizer Inc.
  • 20. RTP Company
  • 21. Sanitized AG
  • 22. Solvay SA
  • 23. Stepan Company
  • 24. Symrise AG
  • 25. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL INGREDIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AUTOMOTIVE & TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BUILDING & CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEXTILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023